Literature DB >> 18781047

Cerebral infarction in a patient with macrothrombocytopenia with leukocyte inclusions (MTCP, May-Hegglin anomaly/Sebastian syndrome).

Yutaka Nishiyama1, Junko Akaishi, Toshiya Katsumata, Ken-ichiro Katsura, Yasuo Katayama.   

Abstract

We report on a 78-year-old woman patient with macrothrombocytopenia with leukocyte inclusions (MTCP, May-Hegglin anomaly/Sebastian syndrome), who had no history of hemorrhagic symptoms and had a platelet count of 10,000 or less, but had a cerebral infarction. The patient was found to have idiopathic thrombocytopenic purpura, hypertension, and atrial fibrillation 16 years ago, yet received no medication. She was found to have had a cerebral infarction with aphasia as the chief complaint and was admitted to our hospital. Thrombocytopenia was found in three family members. Blood examinations revealed normal bleeding time and platelet aggregation ability. The patient was found to have the triad of giant platelets, thrombocytopenia, and inclusion bodies in leukocytes. Genetic analysis showed a mutation of the MYH-9 gene in the patients second daughter. Consequently, this patient received a diagnosis of MTCP. There have only been a few reports of the onset of thrombosis in patients with MTCP and no reports of the onset of cerebral infarction. Our report is the first case of MTCP in a patient with cerebral infarction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781047     DOI: 10.1272/jnms.75.228

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  4 in total

1.  Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes).

Authors:  Antonio Girolami; Girolami Antonio; Silvia Vettore; Vettore Silvia; Emanuela Bonamigo; Bonamigo Emanuela; Fabrizio Fabris; Fabris Fabrizio
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

2.  NMMHC IIA Inhibition Ameliorates Cerebral Ischemic/Reperfusion-Induced Neuronal Apoptosis Through Caspase-3/ROCK1/MLC Pathway.

Authors:  Guang-Yun Wang; Tie-Zheng Wang; Yuan-Yuan Zhang; Fang Li; Bo-Yang Yu; Jun-Ping Kou
Journal:  Drug Des Devel Ther       Date:  2020-01-06       Impact factor: 4.162

3.  Inhibiting YAP in Endothelial Cells From Entering the Nucleus Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury.

Authors:  Shuaishuai Gong; Huifen Ma; Fan Zheng; Juan Huang; Yuanyuan Zhang; Boyang Yu; Fang Li; Junping Kou
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

4.  NMMHC IIA triggers neuronal autophagic cell death by promoting F-actin-dependent ATG9A trafficking in cerebral ischemia/reperfusion.

Authors:  Guangyun Wang; Tiezheng Wang; Yang Hu; Jieman Wang; Yan Wang; Yuanyuan Zhang; Fang Li; Wentao Liu; Yang Sun; Boyang Yu; Junping Kou
Journal:  Cell Death Dis       Date:  2020-06-08       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.